Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Sprr1A as a genetic target for treating neurodegenerative diseases

Sprr1A as a genetic target for treating neurodegenerative diseases

US Patent 11434501 · Granted Sep 6, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Predicting therapeutic response in Parkinson's disease2022
Nurr1 as a genetic target for treating levodopa-induced dyskinesias in Parkinson2018
Nurr1 as a genetic target for treating levodopa-induced dyskinesias in Parkinson2018
Nurr1 as a genetic target for treating levodopa-induced dyskinesias in Parkinson2018
Composition and method for preventing or treating a tauopathy2018
Composition and method for treating a tauopathy2017
Use of pleiotrophin to promote neurogeneration2009
Erythropoietin administration to improve graft survival2008
Dopaminergic neurotrophic factor for treatment of Parkinson's disease1993